Track the 亚辉龙 stock price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 亚辉龙 has logged 14 reports. Market capitalisation: €5.2bn. The latest transaction was reported on 21 July 2026 (Purchase). Among the most active insiders: 胡鹍辉. All data is free.
14
Insider Decl.
n/a
Thresholds
€416,810
4 ops.
Buy Volume
€5m
10 ops.
Sell Volume
22Σ signal
Buys €416,810€5m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,327 of 28,803 companies
43.4
score / 100
Value
38
Quality
49
FCF yld1.1%
Earn yld0.4%
EV/EBITDA15.6x
ROE2.8%
Gross mgn65%
Net mgn1.3%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
亚辉龙 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and production of innovative pharmaceutical products.